Clinical Trials Logo

Hilar Cholangiocarcinoma clinical trials

View clinical trials related to Hilar Cholangiocarcinoma.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04779788 Enrolling by invitation - Clinical trials for Hilar Cholangiocarcinoma

I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Malignant biliary obstruction usually arise in patients suffering from primary or metastatic hepatobiliary tumors. Approximately 80% of malignant biliary obstruction patients are not eligible for surgical resection, and as such palliative stent insertion is the only treatment option available for most patients. At present, I-125 seeds loaded stent has been developed to improve the stent patency and patients' survival. Hilar malignant biliary obstruction is an important part of malignant biliary obstruction. Hilar cholangiocarcinoma is the most common disease which causes hilar malignant biliary obstruction. Herein, we assessed the clinical and long-term efficacy of I-125 seeds loaded stent insertion for hilar cholangiocarcinoma patients.

NCT ID: NCT03739164 Enrolling by invitation - Clinical trials for Hepatocellular Carcinoma

Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)

TAMLAPS
Start date: July 18, 2018
Phase:
Study type: Observational [Patient Registry]

This is a study following the outcomes and survival of patients undergoing the TAMLAPS hepatectomy at Florida Hospital Tampa by Dr. Iswanto Sucandy

NCT ID: NCT01715402 Enrolling by invitation - Clinical trials for Hepatocellular Carcinoma

Optimization of Health Expenditure in Liver Surgery

Start date: September 2012
Phase: N/A
Study type: Observational

The aim of this study is to reduce the length of stay after liver surgery by taking account of objective quantitative clinical variables, subjective qualitative clinical variables and non clinical variables.